Hsbc Holdings PLC Cidara Therapeutics, Inc. Transaction History

Hsbc Holdings PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.45 - $0.81 $8,216 - $14,788	-18,258 Reduced 51.78%	17,001 $11,000
Q2 2022 Aug 11, 2022	SELL	$0.43 - $0.91 $2,094 - $4,433	-4,872 Reduced 12.14%	35,259 $17,000
Q2 2021 Aug 13, 2021	BUY	$1.87 - $2.7 $23,260 - $33,585	12,439 Added 44.92%	40,131 $81,000
Q1 2021 May 14, 2021	BUY	$2.06 - $3.01 $57,045 - $83,352	27,692 New	27,692 $73,000

22.1M

2.7K

100

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $889M
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.